These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1380 related items for PubMed ID: 21810838

  • 1. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A, Madrid cohort of HIV-infected children.
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L.
    Antivir Ther; 2010 Oct; 15(4):641-50. PubMed ID: 20587857
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
    Romero A, Sued O, Puig T, Esteve A, Pumarola T, Casabona J, González V, Matas L, Tural C, Rodrigo I, Margall N, Domingo P, Casanova A, Ferrer E, Caballero E, Ribera E, Farré J, Puig T, Amengual MJ, Navarro G, Prat JM, Masabeu A, Simó JM, Villaverde CA, Barrufet P, Sauca MG, Ortin X, Ortí A, Navarro R, Euras JM, Vilaró J, Villà MC, Montull S, Vilanova C, Pujol F, Díaz O, Miró JM, AERI study Group.
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(7):482-9. PubMed ID: 21543135
    [Abstract] [Full Text] [Related]

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Oct; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
    Franzetti M, Lai A, Simonetti FR, Bozzi G, De Luca A, Micheli V, Meraviglia P, Corsi P, Bagnarelli P, Almi P, Zoncada A, Balotta C.
    J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ, Zelnikar M, Seme K, Vandamme AM, Snoeck J, Tomazic J, Vidmar L, Karner P, Poljak M.
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
    Zhao B, Han X, Dai D, Liu J, Ding H, Xu J, Chu Z, Bice T, Diao Y, Shang H.
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
    [Abstract] [Full Text] [Related]

  • 14. Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure.
    Lwembe R, Ochieng W, Panikulam A, Mongoina CO, Palakudy T, Koizumi Y, Kageyama S, Yamamoto N, Shioda T, Musoke R, Owens M, Songok EM, Okoth FA, Ichimura H.
    J Med Virol; 2007 Jul; 79(7):865-72. PubMed ID: 17516531
    [Abstract] [Full Text] [Related]

  • 15. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Mitrenga D, Beerenwinkel N, Sagir A, Pfister H, Häussinger D.
    Dtsch Med Wochenschr; 2007 May 04; 132(18):977-82. PubMed ID: 17457780
    [Abstract] [Full Text] [Related]

  • 16. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.
    Infect Genet Evol; 2009 Jul 04; 9(4):646-52. PubMed ID: 19460333
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.
    Vignoles M, Barboni G, Agosti MR, Quarleri J, García MK, Ayala SG, Salomón H.
    Antivir Ther; 2009 Jul 04; 14(8):1175-81. PubMed ID: 20032547
    [Abstract] [Full Text] [Related]

  • 18. Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
    Balode D, Westman M, Kolupajeva T, Rozentale B, Albert J.
    J Med Virol; 2010 Dec 04; 82(12):2013-8. PubMed ID: 20981787
    [Abstract] [Full Text] [Related]

  • 19. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis.
    Rojas Sánchez P, Domínguez S, Jiménez De Ory S, Prieto L, Rojo P, Mellado P, Navarro M, Delgado R, Ramos JT, Holguín Á, Madrid Cohort of HIV-1 Infected Children and Adolescents Integrated in the Pediatric Branch of the Spanish National AIDS Network (CoRISPe).
    Pediatr Infect Dis J; 2018 Mar 04; 37(3):e48-e57. PubMed ID: 28991889
    [Abstract] [Full Text] [Related]

  • 20. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
    Mullen J, Leech S, O'Shea S, Chrystie IL, Du Mont G, Ball C, Sharland M, Cottam F, Zuckerman M, Rice P, Easterbrook P.
    J Med Virol; 2002 Nov 04; 68(3):299-304. PubMed ID: 12226814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.